| [1] |
Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: advances in the 21st century[J]. Clin Microbiol Rev, 2019, 32(2):e00075-18.
|
| [2] |
Torgerson PR, Keller K, Magnotta M, et al. The global burden of alveolar echinococcosis[J]. PLoS Negl Trop Dis, 2010, 4(6):e722.
|
| [3] |
McManus DP, Gray DJ, Zhang W, et al. Diagnosis, treatment, and management of echinococcosis[J]. BMJ, 2012, 344: e3866.
|
| [4] |
Torgerson PR, Schweiger A, Deplazes P, et al. Alveolar echinococcosis: from a deadly disease to a well-controlled infection. relative survival and economic analysis in Switzerland over the last 35 years[J]. J Hepatol, 2008, 49(1):72-77.
|
| [5] |
Bulakci M, Ilhan M, Bademler S, et al. Efficacy of ultrasound-guided core-needle biopsy in the diagnosis of hepatic alveolar echinococcosis: a retrospective analysis[J]. Parasite, 2016, 23: 19.
|
| [6] |
Bresson-Hadni S, Delabrousse E, Blagosklonov O, et al. Imaging aspects and non-surgical interventional treatment in human alveolar echinococcosis[J]. Parasitol Int, 2006, 55(Suppl):S267-272.
|
| [7] |
Bulakçı M, Kartal MG, Yılmaz S, et al. Multimodality imaging in diagnosis and management of alveolar echinococcosis: an update[J]. Diagn Interv Radiol, 2016, 22(3):247-256.
|
| [8] |
Vuitton DA, Gottstein B. Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay[J]. J Biomed Biotechnol, 2010:923193.
|
| [9] |
Tappe D, Frosch M, Sako Y, et al. Close relationship between clinical regression and specific serology in the follow-up of patients with alveolar echinococcosis in different clinical stages[J]. Am J Trop Med Hyg, 2009, 80(5):792-797.
|
| [10] |
Brunetti E, Kern P, Vuitton DA, et al. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans[J]. Acta Trop, 2010, 114(1):1-16.
|
| [11] |
Norwitz ER, Levy B. Noninvasive prenatal testing: the future is now[J]. Rev Obstet Gynecol, 2013, 6(2):48-62.
|
| [12] |
Mandel P, Metais P. Nuclear acids in human blood plasma[J]. C R Seances Soc Biol Fil, 1948, 142(3/4):241-243.
|
| [13] |
Leon SA, Shapiro B, Sklaroff DM, et al. Free DNA in the serum of cancer patients and the effect of therapy[J]. Cancer Res, 1977, 37(3):646-650.
|
| [14] |
Stroun M, Anker P, Lyautey J, et al. Isolation and characterization of DNA from the plasma of cancer patients[J]. Eur J Cancer Clin Oncol, 1987, 23(6):707-712.
|
| [15] |
Vasioukhin V, Anker P, Maurice P, et al. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia[J]. Br J Haematol, 1994, 86(4):774-779.
|
| [16] |
Ji J, Li B, Li J, et al. Comprehensive characterization of plasma cell-free Echinococcus spp. DNA in echinococcosis patients using ultra-high-throughput sequencing[J]. PLoS Negl Trop Dis, 2020, 14(4):e0008148.
|
| [17] |
Zhao Y, Gongsang Q, Ji J, et al. Characterizing dynamic changes of plasma cell-free Echinococcus granulosus DNA before and after cystic echinococcosis treatment initiation[J]. Genomics, 2021, 113(2):576-582.
|
| [18] |
Zhao Y, Shen S, Jin X, et al. Cell-free DNA as a diagnostic tool for human echinococcosis[J]. Trends Parasitol, 2021, 37(11):943-946.
|
| [19] |
Russomando G, Figueredo A, Almirón M, et al. Polymerase chain reaction-based detection of Trypanosoma cruzi DNA in serum[J].J Clin Microbiol, 1992, 30(11):2864-2868.
|
| [20] |
Wichmann D, Panning M, Quack T, et al. Diagnosing schistosomiasis by detection of cell-free parasite DNA in human plasma[J]. PLoS Negl Trop Dis, 2009, 3(4):e422.
|
| [21] |
Jiang P, Lo YMD. The long and short of circulating cell-free DNA and the ins and outs of molecular diagnostics[J]. Trends Genet, 2016, 32(6):360-371.
|
| [22] |
Snyder MW, Kircher M, Hill AJ, et al. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin[J]. Cell, 2016, 164(1/2):57-68.
|
| [23] |
Breitbach S, Tug S, Helmig S, et al. Direct quantification of cell-free, circulating DNA from unpurified plasma[J]. PLoS One, 2014, 9(3):e87838.
|
| [24] |
Volik S, Alcaide M, Morin RD, et al. Cell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies[J]. Mol Cancer Res, 2016, 14(10):898-908.
|
| [25] |
Kamat AA, Baldwin M, Urbauer D, et al. Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker[J]. Cancer, 2010, 116(8):1918-1925.
|
| [26] |
Lo YM, Zhang J, Leung TN, et al. Rapid clearance of fetal DNA from maternal plasma[J]. Am J Hum Genet, 1999, 64(1):218-224.
|
| [27] |
Crowley E, Di Nicolantonio F, Loupakis F, et al. Liquid biopsy: monitoring cancer-genetics in the blood[J]. Nat Rev Clin Oncol, 2013, 10(8):472-484.
|
| [28] |
Lo YM, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma[J]. N Engl J Med, 1998, 339(24):1734-1738.
|
| [29] |
Aarthy R, Mani S, Velusami S, et al. Role of circulating cell-free DNA in cancers[J]. Mol Diagn Ther, 2015, 19(6):339-350.
|
| [30] |
Kalluri R, LeBleu VS. Discovery of double-stranded genomic DNA in circulating exosomes[J]. Cold Spring Harb Symp Quant Biol, 2016, 81: 275-280.
|
| [31] |
Kumar M, Choudhury Y, Ghosh SK, et al. Application and optimization of minimally invasive cell-free DNA techniques in oncogenomics[J]. Tumour Biol, 2018, 40(2):1010428318760342.
|
| [32] |
Wagner J. Free DNA-new potential analyte in clinical laboratory diagnostics?[J]. Biochem Med, 2012, 22(1):24-38.
|
| [33] |
Weerakoon KG, McManus DP. Cell-free DNA as a diagnostic tool for human parasitic infections[J]. Trends Parasitol, 2016, 32(5):378-391.
|
| [34] |
Yu J, Gu G, Ju S. Recent advances in clinical applications of circulating cell-free DNA integrity[J]. Lab Med, 2014, 45(1):6-11.
|
| [35] |
Chaya D, Parija SC. Performance of polymerase chain reaction for the diagnosis of cystic echinococcosis using serum, urine, and cyst fluid samples[J]. Trop Parasitol, 2014, 4(1):43-46.
|
| [36] |
Baraquin A, Hervouet E, Richou C, et al. Circulating cell-free DNA in patients with alveolar echinococcosis[J]. Mol Biochem Parasitol, 2018, 222:14-20.
|
| [37] |
Fan H, Gai W, Zhang L, et al. Parasite circulating cell-free DNA in the blood of alveolar echinococcosis patients as a diagnostic and treatment-status indicator[J]. Clin Infect Dis, 2021, 73(1):e246-251.
|
| [38] |
Knapp J, Millon L, Mouzon L, et al. Real time PCR to detect the environmental faecal contamination by Echinococcus multilocularis from red fox stools[J]. Vet Parasitol, 2014, 201(1/2):40-47.
|
| [39] |
Wahlström H, Comin A, Isaksson M, et al. Detection of Echinococcus multilocularis by MC-PCR: evaluation of diagnostic sensitivity and specificity without gold standard[J]. Infect Ecol Epidemiol, 2016, 6: 30173.
|
| [40] |
Wan Z, Peng X, Ma L, et al. Targeted sequencing of genomic repeat regions detects circulating cell-free Echinococcus DNA[J]. PLoS Negl Trop Dis, 2020, 14(3):e0008147.
|
| [41] |
Blauwkamp TA, Thair S, Rosen MJ, et al. Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease[J]. Nat Microbiol, 2019, 4(4):663-674.
|
| [42] |
Heitzer E, Ulz P, Geigl JB. Circulating tumor DNA as a liquid biopsy for cancer[J]. Clin Chem, 2015, 61(1):112-123.
|
| [43] |
Grumaz S, Stevens P, Grumaz C, et al. Next-generation sequencing diagnostics of bacteremia in septic patients[J]. Genome Med, 2016, 8(1):73.
|
| [44] |
Karabulut N. Two other hepatic cystic lesions: alveolar echinococcosis and intraductal papillary mucinous tumor of the bile ducts[J]. AJR Am J Roentgenol, 2015, 204(5):W610.
|
| [45] |
Taback B, O'Day SJ, Hoon DSB. Quantification of circulating DNA in the plasma and serum of cancer patients[J]. Ann N Y Acad Sci, 2004, 1022: 17-24.
|
| [46] |
Underhill HR, Kitzman JO, Hellwig S, et al. Fragment length of circulating tumor DNA[J]. PLoS Genet, 2016, 12(7):e1006162.
|
| [47] |
Kawamura N, Kamiyama T, Sato N, et al. Long-term results of hepatectomy for patients with alveolar echinococcosis: a single-center experience[J]. J Am Coll Surg, 2011, 212(5):804-812.
|
| [48] |
Kadry Z, Renner EC, Bachmann LM, et al. Evaluation of treatment and long-term follow-up in patients with hepatic alveolar echinococcosis[J]. Br J Surg, 2005, 92(9):1110-1116.
|
| [49] |
Kern P, Menezes da Silva A, Akhan O, et al. The echinococcoses: diagnosis, clinical management and burden of disease[J]. Adv Parasitol, 2017, 96: 259-369.
|
| [50] |
Reuter S, Nüssle K, Kolokythas O, et al. Alveolar liver echinococcosis: a comparative study of three imaging techniques[J]. Infection, 2001, 29(3):119-125.
|
| [51] |
Ehrhardt AR, Reuter S, Buck AK, et al. Assessment of disease activity in alveolar echinococcosis: a comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F]fluorodeoxyglucose positron emission tomography[J]. Abdom Imaging, 2007, 32(6):730-736.
|
| [52] |
Gottstein B, Wang J, Blagosklonov O, et al. Echinococcus metacestode: in search of viability markers[J]. Parasite, 2014, 21: 63.
|
| [53] |
Siles-Lucas M, Casulli A, Cirilli R, et al. Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: compounds and therapeutic targets[J]. PLoS Negl Trop Dis, 2018, 12(4):e0006422.
|
| [54] |
Sanchez C, Snyder MW, Tanos R, et al. New insights into structural features and optimal detection of circulating tumor DNA determined by single-strand DNA analysis[J]. NPJ Genom Med, 2018, 3: 31.
|
| [55] |
闫甲，刘双池，王政宇. 胆囊癌肿瘤标志物的研究和应用进展[J/OL]. 中华普通外科学文献(电子版), 2023, 17(5):391-394.
|